We are monitoring the impact of COVID-19 & Recession alarm on APAC CAR T cell Therapy Market Get in touch with us for detailed analysis Know More

Know More

Share on

Asia Pacific CAR T cell Therapy Market Research Report - By Target Antigen, Products, Application, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends and Forecast (2022 to 2027)

Published: January, 2022
ID: 10130
Pages: 100

APAC CAR T cell Therapy Market Size (2022 to 2027)

The CAR T cell Therapy Market size in the Asia Pacific is estimated to grow at a robust CAGR from 2022 to 2027.

Increased funds from the government organizations and the adoption of advanced technologies in the hospitals and clinics are undoubtedly significant factors for the market to grow in the Asia Pacific. It is proven that CAR T cell therapy is very much efficient in treating cancer, and this is elevating the growth rate of the market enormously. Growing older people is one more factor propelling the CAR T cell therapy market's demand in the Asia Pacific. An increasing number of people suffering from chronic diseases is accelerating the size of the market. In the Asia Pacific, more than 2000 clinical trials were going on with this technique, which is solely enhancing the market demand. 

However, this treatment procedure's cost is very high, where ordinary people cannot afford is slowly impeding the growth rate of the CAR T cell therapy market in the Asia Pacific. Stringent rules and regulations by the government in approving new techniques are limiting the demand of the market. Besides, the shortage of skilled professionals in the laboratories to perform clinical trials is hampering the market's demand. Inadequate reimbursement policies in underdeveloped countries are likely to show a negative impact on the growth rate of the market. 

This research report on the Asia Pacific CAR T cell therapy market has been segmented and sub-segmented into the following categories:

By Target Antigen

  • CD20
  • EGFRV III
  • CD19
  • HER2
  • MESO
  • CD22
  • BCMA
  • GD2
  • CD30
  • HER1
  • CD33

By Application

  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Mantle Cell Lymphoma
  • Follicular Lymphoma
  • Diffuse large B-cell lymphoma
  • Acute Lymphoblastic Leukemia

By Product

  • Allogeneic
  • Autologous

By Therapies:

  • Axicabtagene ciloleucel (Yescarta)
  • Tisagenlecleucel (Kymriah)

By End-User

  • Cancer Research Centers
  • Hospitals
  • Academic and Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations

Country-Level Analysis:

Asia Pacific is estimated to reach the highest CAGR in the coming years. Growing knowledge over the availability of different treatment procedures through digital advertisements bolsters the CAR T cell therapy market's growth. 

China is leading with the highest shares of the market by owing to the increasing number of hospitals with excellent infrastructure. The launch of innovative techniques with advanced technologies is surging the demand of the market. According to the recent survey, around 4.3 million people have cancer in China. 

India is next to China in dominating the shares of the CAR T cell therapy market. The number of cancer cases in India is projected to surge in the coming years due to lifestyle changes. Increasing pharmaceutical companies and a rise in the number of clinical trials are fuelling the market's growth rate. The introduction of these techniques to treat cancer is elevating this market's demand for this country's extent.

Japan is esteemed to have significant growth opportunities in the coming years with the growing economy from the past few years. Also, focusing on improving the quality of healthcare services by introducing various techniques is boosting market demand.  

Notable companies in the APAC CAR T Cell Therapy Market profiled in this report are Mustang Bio, Inc., Celgene Corporation, Bluebird Bio, Inc., CARsgen Therapeutics, Ltd., Novartis International AG, Legend Biotech, Sorrento Therapeutics Inc., Kite Pharma, Inc., Immune Therapeutics, Bellicum Pharmaceuticals, Inc. and Pfizer, Inc.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. By Target Antigen
      1. CD20
      2. EGFRV III
      3. CD19
      4. HER2
      5. MESO
      6. CD22
      7. BCMA
      8. GD2
      9. CD30
      10. HER1
      11. CD33
      12. Y-o-Y Growth Analysis, By Target Antigen
      13. Market Attractiveness Analysis, By Target Antigen
      14. Market Share Analysis, By Target Antigen
    2. By Application
      1. Multiple Myeloma
      2. Chronic Lymphocytic Leukemia
      3. Mantle Cell Lymphoma
      4. Follicular Lymphoma
      5. Diffuse large B-cell lymphoma
      6. Acute Lymphoblastic Leukemia
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Product
      1. Allogeneic
      2. Autologous
      3. Y-o-Y Growth Analysis, By Product
      4. Market Attractiveness Analysis, By Product
      5. Market Share Analysis, By Product
    4. By Therapies
      1. Axicabtagene ciloleucel (Yescarta)
      2. Tisagenlecleucel (Kymriah)
      3. Y-o-Y Growth Analysis, By Therapies
      4. Market Attractiveness Analysis, By Therapies
      5. Market Share Analysis, By Therapies
    5. By End User
      1. Cancer Research Centers
      2. Hospitals
      3. Academic and Research Institutes
      4. Pharmaceutical Companies
      5. Biotechnology Companies
      6. Contract Research Organizations
      7. Y-o-Y Growth Analysis, By End User
      8. Market Attractiveness Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia Pacific
      1. India
      2. China
      3. Japan
      4. South Korea
      5. Australia
      6. New Zealand
      7. Thailand
      8. Malaysia
      9. Vietnam
      10. Philippines
      11. Indonesia
      12. Singapore
      13. Rest of APAC
  7. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. MARKET LEADERS' ANALYSIS
    1. Mustang Bio, Inc.,
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Celgene Corporation
    3. Bluebird Bio, Inc.
    4. CARsgen Therapeutics, Ltd.
    5. Novartis International AG
    6. Legend Biotech
    7. Sorrento Therapeutics Inc.
    8. Kite Pharma, Inc.
    9. Immune Therapeutics
    10. Bellicum Pharmaceuticals, Inc.
    11. Pfizer, Inc.
  9. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  11. APPENDIX
    1. List of Tables
    2. List of Figures
  1. Asia Pacific Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  2. Asia Pacific CD 20 Market, By Region, From 2022 - 2027 (USD Million)
  3. Asia Pacific EGFRV III Market, By Region, From 2022 - 2027 (USD Million)
  4. Asia Pacific CD 19 Market, By Region, From 2022 - 2027 (USD Million)
  5. Asia Pacific HER 2 Market, By Region, From 2022 - 2027 (USD Million)
  6. Asia Pacific MESO Market, By Region, From 2022 - 2027 (USD Million)
  7. Asia Pacific CD 22 Market, By Region, From 2022 - 2027 (USD Million)
  8. Asia Pacific BCMA Market, By Region, From 2022 - 2027 (USD Million)
  9. Asia Pacific GD 2 Market, By Region, From 2022 - 2027 (USD Million)
  10. Asia Pacific CD 30 Market, By Region, From 2022 - 2027 (USD Million)
  11. Asia Pacific HER 1 Market, By Region, From 2022 - 2027 (USD Million)
  12. Asia Pacific Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  13. Asia Pacific Multiple Myeloma Market, By Region, From 2022 - 2027 (USD Million)
  14. Asia Pacific Chronic Lymphocytic Leukemia Market, By Region, From 2022 - 2027 (USD Million)
  15. Asia Pacific Mantle Cell Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  16. Asia Pacific Follicular Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  17. Asia Pacific Diffuse large B-cell Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  18. Asia Pacific Acute Lymphoblastic Leukemia Market, By Region, From 2022 - 2027 (USD Million)
  19. Asia Pacific Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  20. Asia Pacific Allogeneic Market, By Region, From 2022 - 2027 (USD Million)
  21. Asia Pacific Autologous Market, By Region, From 2022 - 2027 (USD Million)
  22. Asia Pacific Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  23. Asia Pacific Axicabtagene Ciloleucel (Yescarta) Market, By Region, From 2022 - 2027 (USD Million)
  24. Asia Pacific Tisagenlecleucel (Kymriah) Market, By Region, From 2022 - 2027 (USD Million)
  25. Asia Pacific Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  26. Asia Pacific Cancer Reasearch Centers Market, By Region, From 2022 - 2027 (USD Million)
  27. Asia Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  28. Asia Pacific Academic and Research institutes Market, By Region, From 2022 - 2027 (USD Million)
  29. Asia Pacific Pharmaceutical Companies Market, By Region, From 2022 - 2027 (USD Million)
  30. Asia Pacific Biotechnology Companies  Market, By Region, From 2022 - 2027 (USD Million)
  31. Asia Pacific Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Million)
  32. Japan Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  33. Japan Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  34. Japan Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  35. Japan Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  36. Japan Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  37. China Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  38. China Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  39. China Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  40. China Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  41. China Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  42. India Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  43. India Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  44. India Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  45. India Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  46. India Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  47. Australia Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  48. Australia Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  49. Australia Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  50. Australia Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  51. Australia Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)
  52. South Korea Global CAR T cell Therapy Market, By Target Antigen, From 2022 - 2027 (USD Million)
  53. South Korea Global CAR T cell Therapy Market, By Application, From 2022 - 2027 (USD Million)
  54. South Korea Global CAR T cell Therapy Market, By Product, From 2022 - 2027 (USD Million)
  55. South Korea Global CAR T cell Therapy Market, By Therapies, From 2022 - 2027 (USD Million)
  56. South Korea Global CAR T cell Therapy Market, By End-User, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample